Wydawnictwo Medyczne Mediton
quarterly

Under the scientific patronage of

the Polish Society of Audiology and Phoniatrics

 

Original articles

« return
Treatment options in infantile hemangiomas
Beata Pucher 1/, Katarzyna Jończyk-Potoczna 2/, Jakub Sroczyński 1/, Magdalena Prauzińska 1/, Michał Kotowski 1/, Bartosz Polski 1/, Michał Grzegorowski 1/, Jarosław Szydłowski 1/
  • 1/ Klinika Otolaryngologii Dziecięcej Katedry Otolaryngologii Uniwersytetu Medycznego im. K. Marcinkowskiego w Poznaniu
  • 2/ Zakład Radiologii Pediatrycznej Szpitala Klinicznego im. K. Jonschera Uniwersytetu Medycznego im. K. Marcinkowskiego w Poznaniu

Introduction. Infantile hemangiomas are one of the most common benign tumors and affect approximately 1-2% infants. Congenital subglottic hemangiomas are the most common respiratory tract neoplasms in children and may result in respiratory failure which can be fatal.
Aim. Evaluation of different methods of treatment of infantile hemangiomas.
Materials and methods. The study included 18 children – 6 with laryngeal hemangioma, 1 with concomitant skin hemangioma,
2 with hemangioma piriform recess, 4 within the parotid gland, 3 with hemangioma of the scalp, 2 – with location on the tongue, 1 with nose hemangioma and 1 situated in trachea. Patients were hospitalized in the Department of Pediatric Otolaryngology in 2010-2014.
Results. In 6 cases, treatment with propranolol was instituted. In 2 children with subglottic hemangioma the tracheotomy was performed, 1 child required tracheal intubation immediately. In 7 cases, tumors were removed by surgery (in 4 cases by endoscopy and in 3 with the use of CO2 laser).
Conclusions. Propranolol treatment of infantile hemangiomas is associated with minimal risk of side effects and can be continued at home. Its effectiveness causes that protracted use of setroids, prolonged intubation or even surgical intervention are no longer necessary.

Otorynolaryngologia vol 14. no 1. Marchpages: from 25to 29
full version